Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MANH
MANH logo

MANH Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Manhattan Associates Inc (MANH) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
132.280
1 Day change
0.14%
52 Week Range
247.220
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Manhattan Associates Inc (MANH) does not currently present a compelling buy opportunity for a beginner, long-term investor with $50,000-$100,000 available. The technical indicators are bearish, insider selling has increased significantly, and there are no strong positive catalysts or trading signals to suggest immediate upside potential. Holding off on investment until stronger signals or improved sentiment emerge is recommended.

Technical Analysis

The MACD histogram is -2.013, below 0, and negatively expanding, indicating bearish momentum. The RSI_6 is at 23.612, which is neutral but leaning towards oversold territory. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support is at 130.964, with resistance at 140.584. The stock is trading near its support level, but no reversal signals are present.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

The high Option Volume Put-Call Ratio (2.97) indicates bearish sentiment among options traders, with significantly more put volume than call volume. Implied volatility is high at 51.5, suggesting elevated uncertainty.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
4

Positive Catalysts

  • NULL identified. Analyst ratings remain generally positive with 'Buy' and 'Overweight' ratings, but price targets have been lowered recently. The company has shown strong bookings momentum in the past, but no recent financial data is available to confirm ongoing growth.

Neutral/Negative Catalysts

  • Insider selling has increased by 102.09% over the last month, signaling potential lack of confidence from insiders. Legal investigations by Rosen Law Firm into fiduciary breaches could weigh on sentiment. Technical indicators and options data suggest bearish trends.

Financial Performance

No financial data available for the latest quarter. Analysts previously noted strong bookings momentum and raised guidance, but recent price target reductions reflect concerns over valuation and market conditions.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts maintain positive ratings (Buy/Overweight), but recent price target reductions (e.g., Barclays lowered from $239 to $201, Citi from $208 to $177) suggest caution. The reductions are attributed to valuation resets and market conditions rather than company-specific issues.

Wall Street analysts forecast MANH stock price to rise
8 Analyst Rating
Wall Street analysts forecast MANH stock price to rise
6 Buy
2 Hold
0 Sell
Strong Buy
Current: 132.090
sliders
Low
165
Averages
224.57
High
250
Current: 132.090
sliders
Low
165
Averages
224.57
High
250
Barclays
Guy Hardwick
Overweight
downgrade
$239 -> $201
AI Analysis
2026-05-29
Reason
Barclays
Guy Hardwick
Price Target
$239 -> $201
AI Analysis
2026-05-29
downgrade
Overweight
Reason
Barclays analyst Guy Hardwick lowered the firm's price target on Manhattan Associates to $201 from $239 and keeps an Overweight rating on the shares. The firm adjusted estimates and targets among its Industrial Tech coverage.
Barclays
NULL -> Overweight
maintain
$236 -> $239
2026-04-23
Reason
Barclays
Price Target
$236 -> $239
2026-04-23
maintain
NULL -> Overweight
Reason
Barclays raised the firm's price target on Manhattan Associates to $239 from $236 and keeps an Overweight rating on the shares post the Q1 report. The company posted its second strongest quarterly bookings on record, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MANH
Unlock Now

People Also Watch